120 related articles for article (PubMed ID: 10639287)
1. Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic delta opioid receptor ligands.
Zhang X; Rice KC; Calderon SN; Kayakiri H; Smith L; Coop A; Jacobson AE; Rothman RB; Davis P; Dersch CM; Porreca F
J Med Chem; 1999 Dec; 42(26):5455-63. PubMed ID: 10639287
[TBL] [Abstract][Full Text] [Related]
2. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
3. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
[TBL] [Abstract][Full Text] [Related]
4. De novo design, synthesis, and biological activities of high-affinity and selective non-peptide agonists of the delta-opioid receptor.
Liao S; Alfaro-Lopez J; Shenderovich MD; Hosohata K; Lin J; Li X; Stropova D; Davis P; Jernigan KA; Porreca F; Yamamura HI; Hruby VJ
J Med Chem; 1998 Nov; 41(24):4767-76. PubMed ID: 9822547
[TBL] [Abstract][Full Text] [Related]
5. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers.
Furness MS; Zhang X; Coop A; Jacobson AE; Rothman RB; Dersch CM; Xu H; Porreca F; Rice KC
J Med Chem; 2000 Aug; 43(16):3193-6. PubMed ID: 10956228
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
Knapp RJ; Santoro G; De Leon IA; Lee KB; Edsall SA; Waite S; Malatynska E; Varga E; Calderon SN; Rice KC; Rothman RB; Porreca F; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1996 Jun; 277(3):1284-91. PubMed ID: 8667189
[TBL] [Abstract][Full Text] [Related]
7. Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist.
Calderon SN; Rothman RB; Porreca F; Flippen-Anderson JL; McNutt RW; Xu H; Smith LE; Bilsky EJ; Davis P; Rice KC
J Med Chem; 1994 Jul; 37(14):2125-8. PubMed ID: 8035418
[No Abstract] [Full Text] [Related]
8. New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability.
Plobeck N; Delorme D; Wei ZY; Yang H; Zhou F; Schwarz P; Gawell L; Gagnon H; Pelcman B; Schmidt R; Yue SY; Walpole C; Brown W; Zhou E; Labarre M; Payza K; St-Onge S; Kamassah A; Morin PE; Projean D; Ducharme J; Roberts E
J Med Chem; 2000 Oct; 43(21):3878-94. PubMed ID: 11052793
[TBL] [Abstract][Full Text] [Related]
9. Diaryldimethylpiperazine ligands with mu- and delta-opioid receptor affinity: Synthesis of (+)-4-[(alphaR)-alpha-(4-allyl-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide and (-)-4-[(alphaR)-alpha-(2S,5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N-phenylbenzamide.
Kim IJ; Ullrich T; Janetka JW; Furness MS; Jacobson AE; Rothman RB; Dersch CM; Flippen-Anderson JL; George C; Rice KC
Bioorg Med Chem; 2003 Nov; 11(22):4761-8. PubMed ID: 14556791
[TBL] [Abstract][Full Text] [Related]
10. 3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptors.
Bishop MJ; Garrido DM; Boswell GE; Collins MA; Harris PA; McNutt RW; O'Neill SJ; Wei K; Chang KJ
J Med Chem; 2003 Feb; 46(4):623-33. PubMed ID: 12570383
[TBL] [Abstract][Full Text] [Related]
11. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
Jutkiewicz EM; Baladi MG; Folk JE; Rice KC; Woods JH
J Pharmacol Exp Ther; 2008 Feb; 324(2):714-24. PubMed ID: 17986650
[TBL] [Abstract][Full Text] [Related]
12. DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats.
Holt JD; Watson MJ; Chang JP; O'Neill SJ; Wei K; Pendergast W; Gengo PJ; Chang KJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):601-8. PubMed ID: 16020629
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.
Thomas JB; Herault XM; Rothman RB; Atkinson RN; Burgess JP; Mascarella SW; Dersch CM; Xu H; Flippen-Anderson JL; George CF; Carroll FI
J Med Chem; 2001 Mar; 44(6):972-87. PubMed ID: 11300879
[TBL] [Abstract][Full Text] [Related]
14. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vivo brain distribution of carbon-11-labeled δ-opioid receptor agonists.
Pichika R; Jewett DM; Sherman PS; Traynor JR; Husbands SM; Woods JH; Kilbourn MR
Nucl Med Biol; 2010 Nov; 37(8):989-96. PubMed ID: 21055630
[TBL] [Abstract][Full Text] [Related]
17. Probes for narcotic receptor-mediated phenomena. 20. Alteration of opioid receptor subtype selectivity of the 5-(3-hydroxyphenyl)morphans by application of the message-address concept: preparation of delta-opioid receptor ligands.
Bertha CM; Flippen-Anderson JL; Rothman RB; Porreca F; Davis P; Xu H; Becketts K; Cha XY; Rice KC
J Med Chem; 1995 Apr; 38(9):1523-37. PubMed ID: 7739011
[TBL] [Abstract][Full Text] [Related]
18. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
19. Exploring the structure-activity relationships of [1-(4-tert-butyl-3'-hydroxy)benzhydryl-4-benzylpiperazine] (SL-3111), a high-affinity and selective delta-opioid receptor nonpeptide agonist ligand.
Alfaro-Lopez J; Okayama T; Hosohata K; Davis P; Porreca F; Yamamura HI; Hruby VJ
J Med Chem; 1999 Dec; 42(26):5359-68. PubMed ID: 10639279
[TBL] [Abstract][Full Text] [Related]
20. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
Chang KJ; Rigdon GC; Howard JL; McNutt RW
J Pharmacol Exp Ther; 1993 Nov; 267(2):852-7. PubMed ID: 8246159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]